GlaxoSmithKline (GSK)

Create an Alert
52.48 -0.27  -0.50%   NYSE Jun 18, 5:00PM BATS Real time Currency in USD

GlaxoSmithKline EPS Diluted Quarterly:

0.5957 for March 31, 2013
View Full Chart

GlaxoSmithKline EPS Diluted Quarterly Chart

    GlaxoSmithKline Historical EPS Diluted Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.5957
    Dec. 31, 2012 0.5671
    Sept. 30, 2012 0.7337
    June 30, 2012 0.779
    March 31, 2012 0.8299
    Dec. 31, 2011 0.767
    Sept. 30, 2011 0.8473
    June 30, 2011 0.6907
    March 31, 2011 0.9478
    Dec. 31, 2010 -0.4202
    Sept. 30, 2010 0.7933
    June 30, 2010 -0.1776
    March 31, 2010 0.7869
    Dec. 31, 2009 1.022
    Sept. 30, 2009 0.8337
    June 30, 2009 0.9312
    March 31, 2009 0.6326
    Dec. 31, 2008 0.5614
    Sept. 30, 2008 0.7204
       
    June 30, 2008 0.9735
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro

    About Earnings per Share

    Earnings per share (EPS) the amount of income that "belongs" to each share of common stock. An important tool for investors, EPS is often used in determining the value of a stock.

    The average number of shares outstanding (the denominator of the EPS formula) is usually calculated by averaging the number of shares at the beginning of the earning period and the number of shares at the end of the period. For example, if a company earned $1 million in 2009 and had 900,000 shares at the beginning of 2009 and 1.1 million shares at the end of 2009, the 2009 EPS would be $1 million/[(.9 million shares + 1.1 million shares)/2] = $1/share.

    EPS is generally reported in annualized form from the most recent fiscal year. From time to time, you will see the abbreviation (ttm) associated with earnings per share. That means that the earnings number is a sum of the previous four quarters, which is not necessarily the same as the previous fiscal year.
    Learn More

    Get data for

    GSK EPS Diluted Quarterly Benchmarks

    Companies
    AstraZeneca 0.81
    Merck 0.52
    Eli Lilly and Company 1.42

    GSK EPS Diluted Quarterly Range, Past 5 Years

    Minimum -0.4202 Dec 2010
    Maximum 1.022 Dec 2009
    Average 0.6708

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');